000 01576 a2200481 4500
005 20250514032135.0
264 0 _c20020521
008 200205s 0 0 eng d
022 _a0029-5566
040 _aNLM
_beng
_cNLM
100 1 _aBrink, I
245 0 0 _aLymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
_h[electronic resource]
260 _bNuklearmedizin. Nuclear medicine
_cApr 2002
300 _a108-13 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiological Transport
650 0 4 _aFalse Negative Reactions
650 0 4 _aFalse Positive Reactions
650 0 4 _aFemale
650 0 4 _aFluorodeoxyglucose F18
_xadministration & dosage
650 0 4 _aHead and Neck Neoplasms
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aLymph Nodes
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
_xdiagnostic imaging
650 0 4 _aNeoplasm Staging
650 0 4 _aObserver Variation
650 0 4 _aRadiopharmaceuticals
_xadministration & dosage
650 0 4 _aReproducibility of Results
650 0 4 _aTomography, Emission-Computed
650 0 4 _aUltrasonography
700 1 _aKlenzner, Th
700 1 _aKrause, Th
700 1 _aMix, M
700 1 _aRoss, U H
700 1 _aMoser, E
700 1 _aNitzsche, E U
773 0 _tNuklearmedizin. Nuclear medicine
_gvol. 41
_gno. 2
_gp. 108-13
999 _c11888873
_d11888873